KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Invested Capital (2018 - 2025)

Historic Invested Capital for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $796.1 million.

  • Vir Biotechnology's Invested Capital fell 3583.62% to $796.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $796.1 million, marking a year-over-year decrease of 3583.62%. This contributed to the annual value of $1.2 billion for FY2024, which is 2664.96% down from last year.
  • Per Vir Biotechnology's latest filing, its Invested Capital stood at $796.1 million for Q3 2025, which was down 3583.62% from $947.5 million recorded in Q2 2025.
  • Over the past 5 years, Vir Biotechnology's Invested Capital peaked at $2.1 billion during Q3 2022, and registered a low of $675.4 million during Q1 2021.
  • In the last 5 years, Vir Biotechnology's Invested Capital had a median value of $1.4 billion in 2024 and averaged $1.4 billion.
  • Per our database at Business Quant, Vir Biotechnology's Invested Capital soared by 19629.24% in 2022 and then tumbled by 3583.62% in 2025.
  • Over the past 5 years, Vir Biotechnology's Invested Capital (Quarter) stood at $1.4 billion in 2021, then surged by 45.12% to $2.1 billion in 2022, then fell by 23.47% to $1.6 billion in 2023, then decreased by 26.65% to $1.2 billion in 2024, then plummeted by 31.75% to $796.1 million in 2025.
  • Its last three reported values are $796.1 million in Q3 2025, $947.5 million for Q2 2025, and $1.1 billion during Q1 2025.